TY  - GEN
AU  - McKibbin,Martin
AU  - Ali,Manir
AU  - Bansal,Shveta
AU  - Baxter,Paul D
AU  - West,Kumi
AU  - Williams,Grange
AU  - Cassidy,Frances
AU  - Inglehearn,Chris F
TI  - CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration
SN  - 1468-2079
PY  - 2012///0301
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Complement Factor H
KW  - genetics
KW  - Female
KW  - Fluorescein Angiography
KW  - Genotype
KW  - High-Temperature Requirement A Serine Peptidase 1
KW  - Humans
KW  - Indocyanine Green
KW  - Intravitreal Injections
KW  - Male
KW  - Pilot Projects
KW  - Polymerase Chain Reaction
KW  - Polymorphism, Single Nucleotide
KW  - Promoter Regions, Genetic
KW  - Ranibizumab
KW  - Serine Endopeptidases
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - Visual Acuity
KW  - physiology
KW  - Wet Macular Degeneration
KW  - drug therapy
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1136/bjo.2010.193680
ER  -